Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
5(36%)
Results Posted
22%(2 trials)

Phase Distribution

Ph not_applicable
10
71%
Ph phase_1
1
7%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

14

all time

Status Distribution
Active(5)
Completed(9)

Detailed Status

Completed9
Recruiting4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
5
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

completed964%
recruiting429%
active_not_recruiting17%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14